Premas Biotech Profile
Key Indicators
- Authorised Capital ₹ 33.50 Cr
- Paid Up Capital ₹ 23.45 Cr
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.00 Cr
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth 26.97%
- Profit Growth 69.00%
- Ebitda 13.21%
- Net Worth 33.35%
- Total Assets 52.12%
About Premas Biotech
Premas Biotech Private Limited (PBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 November 2005 and has a history of 19 years and two months. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 33.50 Cr and a paid-up capital of Rs 23.45 Cr.
The company currently has active open charges totaling ₹26.00 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Premas Biotech Private Limited India is Neha Garg as COMPANY SECRETARY. Avijit Das, Prabuddha Kundu, Goutam Das, and Two other members serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232HR2005PTC035932
- Company No.
035932
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2005
- Date of AGM
27 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Premas Biotech Private Limited offer?
Premas Biotech Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Data Entry & Data Processing Service, Data Management, Diagnostic Imaging & Pathology Labs, Medical Test Services, Pharmaceutical Services, Molecular Biology Services, Nutraceuticals & Dietary Supplements, Nutraceuticals.
Who are the key members and board of directors at Premas Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabuddha Kundu  | Managing Director | 17-Oct-2011 | Current |
| Neha Garg | Company Secretary | 21-Sep-2018 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saumen Chakraborty | Director | 29-Apr-2022 | Current |
| Nupur Mehrotra | Director | 05-Jan-2018 | Current |
| Avijit Das | Director | 13-Jan-2006 | Current |
| Goutam Das | Director | 12-Jul-2012 | Current |
Financial Performance of Premas Biotech.
Premas Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.97% increase. The company also saw a substantial improvement in profitability, with a 69% increase in profit. The company's net worth Soared by an impressive increase of 33.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Premas Biotech?
In 2022, Premas Biotech had a promoter holding of 95.59% and a public holding of 4.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clininvent Research Private LimitedGoutam Das is a mutual person
Tcg Lifesciences Private LimitedGoutam Das is a mutual person
Premas Life Sciences Private LimitedAvijit Das is a mutual person
Granules India LimitedSaumen Chakraborty is a mutual person
Krishna Institute Of Medical Sciences LimitedSaumen Chakraborty is a mutual person
Kestrel Renewable Energy Solutions Private LimitedAvijit Das and Prabuddha Kundu are mutual person
Charges (Loans)
₹26.00 Cr
₹1.00 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 24.00 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹2.00 Cr | Open |
| 11 Mar 2022 | Hdfc Bank Limited | ₹12.00 Cr | Open |
| 07 Sep 2021 | Hdfc Bank Limited | ₹12.00 Cr | Open |
| 05 Jul 2013 | Canara Bank | ₹1.00 Cr | Satisfied |
How Many Employees Work at Premas Biotech?
Premas Biotech has a workforce of 109 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premas Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
